You are here: Industry Insights > eye

News List

Older Americans Generally Current With Eye Exams drugs
June 25, 2019
Older Americans Generally Current With Eye Exams.
Did 'Puppy Dog Eyes' Evolve to Please Humans? drugs
June 18, 2019
Did 'Puppy Dog Eyes' Evolve to Please Humans?
Novartis Buys Dry Eye Drug from Takeda for $5.3B contractpharma
May 16, 2019
Takeda also divests TachoSil to Ethicon for $400 million.
Novartis to acquire Xiidra®, expanding front-of-eye portfolio and strengthening leadership in eye care worldpharmanews
May 15, 2019
Novartis to acquire Xiidra®, expanding front-of-eye portfolio and strengthening leadership in eye care.
Novartis to Acquire Xiidra® americanpharmaceuticalreview
May 10, 2019
Novartis to Acquire Xiidra®
Takeda to divest dry eye drug to Novartis in $5.3bn deal pharmaceutical-technology
May 10, 2019
Takeda Pharmaceutical has signed an agreement to sell its Xiidra 5% drug to Novartis for a total consideration of up to $5.3bn.
Implandata Successfully Gains CE Mark for its EYEMATE System for an Orphan Eye Indication b3cnewswire
May 05, 2019
Implandata Successfully Gains CE Mark for its EYEMATE System for an Orphan Eye Indication.
New phase 3 data paints fuller picture for Horizon’s teprotumumab: AACE fiercebiotech
April 29, 2019
On the back of a successful phase 3 study, Horizon Pharma said in February that its inflammatory eye drug was headed for an FDA filing midyear.
Regeneron and Alnylam partner on eye and CNS disease therapies pharmaceutical-technology
April 23, 2019
Regeneron and Alnylam partner on eye and CNS disease therapies.
Direct eye injections best treat uveitic macular edema: study europeanpharmaceuticalreview
April 18, 2019
Direct eye injections treat uveitic macular edema more effectively than treatments placed adjacent to the eye, reveals new Mount Sinai research…

Previous page 1 2 3 Next page